Question

Difficulty: MediumDepressive Disorders

A 31-year-old accountant visits the family medicine clinic accompanied by his partner. He reports a 5-week history of profound sadness, decreased energy, and difficulty concentrating. He states that he sleeps up to 14 hours a day and has gained 6 kg (13 lbs) over the past month. He describes a persistent sensation that his arms and legs are "weighed down by lead." His partner notes that his mood occasionally brightens for a few hours when they go out to his favorite restaurant, but he quickly reverts to feeling depressed. He has missed several days of work. He has no significant past medical history. Family history is notable for a mother who was hospitalized multiple times for erratic behavior and severe mood swings. Physical examination and basic laboratory studies, including thyroid function tests, are within normal limits. The physician determines that the patient is experiencing a major depressive episode. Which of the following is the most critical next step in management prior to initiating pharmacotherapy?

  1. Elicit a history of distinct periods of decreased need for sleep and increased goal-directed activityAnswer
  2. B
    Initiate empirical monotherapy with a selective serotonin reuptake inhibitor
  3. C
    Assess for the presence of third-person auditory hallucinations
  4. D
    Request a comprehensive urine toxicology screen to rule out substance use
  5. E
    Recommend light therapy as a primary intervention for his symptoms

Answer

The most critical next step is to elicit a history of distinct periods of decreased need for sleep and increased goal-directed activity to screen for a history of hypomania or mania.
This patient is experiencing a major depressive episode with atypical features, which include mood reactivity, hypersomnia, hyperphagia, and leaden paralysis. Atypical features, combined with a strong family history of erratic behavior and psychiatric hospitalizations, significantly increase the pre-test probability that this depressive episode is a manifestation of bipolar disorder rather than unipolar major depressive disorder. Before establishing a diagnosis of unipolar depression and initiating pharmacological treatment, it is absolutely critical to screen for a history of mania or hypomania (e.g., decreased need for sleep, grandiosity, increased goal-directed activity). Prescribing an antidepressant to a patient with unrecognized bipolar disorder can precipitate a dangerous manic switch.

Step-by-Step Solution

1
Analyze the patient's specific depressive symptoms and historical context.
The patient presents with a major depressive episode characterized by atypical features (hypersomnia, hyperphagia/weight gain, leaden paralysis, and mood reactivity) alongside a family history highly suspicious for bipolar disorder.
Identifying these specific subtype features is crucial because atypical depression has a high correlation with bipolar disorder.
2
Determine the diagnostic requirements for major depressive disorder.
The DSM-5 criteria for major depressive disorder explicitly require that there has never been a manic or hypomanic episode.
Unipolar depression and bipolar depression share depressive symptoms but require completely different pharmacological approaches.
3
Identify the risk associated with the next management step.
Before initiating any pharmacotherapy, the physician must screen for past manic/hypomanic episodes to avoid prescribing an antidepressant monotherapy.
Treating unrecognized bipolar depression with a selective serotonin reuptake inhibitor (SSRI) or other antidepressant monotherapy carries a high risk of inducing a manic switch.

Key Concept

Patients presenting with a major depressive episode—especially those with atypical features (hypersomnia, weight gain, leaden paralysis, mood reactivity) and a family history of mood disorders—must be carefully screened for past manic or hypomanic episodes before initiating antidepressant therapy to prevent an iatrogenic manic switch.
Estimated Time:1m 0s
Rate this question